Dimensional Fund Advisors
GHDX

Dimensional Fund Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Dimensional Fund Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-371,281
Closed -$25.2M – 3443
2019
Q3 		$25.2M Buy
371,281
+52,159
+16% +$3.58M 0.01% 1875
2019
Q2 		$18.6M Buy
319,122
+97,367
+44% +$5.77M 0.01% 2089
2019
Q1 		$15.5M Buy
221,755
+179,943
+430% +$13.3M 0.01% 2196
2018
Q4 		$2.69M Buy
+41,812
New +$2.93M ﹤0.01% 2777
2015
Q1 		– Sell
-200
Closed -$6K – 3425
2014
Q4 		$6K Hold
200
– – ﹤0.01% 3474
2014
Q3 		$6K Hold
200
– – ﹤0.01% 3500
2014
Q2 		$5K Hold
200
– – ﹤0.01% 3561
2014
Q1 		$5K Sell
200
-64
-24% -$1.84K ﹤0.01% 3570
2013
Q4 		$8K Sell
264
-17,962
-99% -$570K ﹤0.01% 3507
2013
Q3 		$557K Hold
18,226
– – ﹤0.01% 3172
2013
Q2 		$578K Buy
+18,226
New +$599K ﹤0.01% 3141

Dimensional Fund Advisors's GHDX Position: Q4 2019 in Review

Dimensional Fund Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 371,281 shares — an estimated $25.2M sold.

Dimensional Fund Advisors first reported a position in GHDX in Q2 2013 and held it in 11 quarters. The position peaked at $25.2M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Dimensional Fund Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Dimensional Fund Advisors sold 371,281 Genomic Health, Inc. shares in Q4 2019, an estimated $25.2M.
  • Dimensional Fund Advisors first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 11 quarters.
  • Dimensional Fund Advisors's Genomic Health, Inc. position peaked at $25.2M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Dimensional Fund Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.